Protocol-based treatment of septic shock, fibrinolysis for submassive pulmonary embolism, and use of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 7, 2014, Pages 827-828

  Sharma, Nirmal ^a   Venado, Aida ^a   Morrison, Joshua ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FIBRINOLYTIC AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; HEPARIN; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; FIBRINOLYSIS; FLUID RESUSCITATION; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG EMBOLISM; NOTE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; ACUTE DISEASE; AGED; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIAL; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; AGED; CLINICAL PROTOCOLS; DRUG THERAPY, COMBINATION; FIBRINOLYSIS; HEPARIN; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; RESPIRATION, ARTIFICIAL; SHOCK, SEPTIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84925354175     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1055RR     Document Type: Note

References (9)

1. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, et al.; ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683-1693.
2. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
3. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012;308:1566-1572.
4. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, et al.; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402-1411.
5. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014;311:2414-2421.
6. Abroug F, Ouanes-Besbes L, Fkih-Hassen M, Ouanes I, Ayed S, Dachraoui F, Brochard L, Elatrous S. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J 2014;43:717-724.
7. Similowski T, Suissa S. Systemic steroids in severe forms of COPD exacerbations: a question of balance? Eur Respir J 2014;43:668-670.
8. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013;162:237-251.
9. Alía I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, Torres A, Gordo F, Elizalde JJ, de Pablo R, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med 2011;171:1939-1946.